The extent of injection site infection in injecting drug users: Findings from a national surveillance study

V. D. Hope, A. Marongiu, John Parry, Fortune Ncube

    Research output: Contribution to journalArticlepeer-review

    29 Citations (Scopus)

    Abstract

    Injection site infections in injecting drug users (IDUs) are associated with serious morbidity and healthcare costs. Factors associated with symptoms of these were examined through annual (2006-2008) unlinked-anonymous survey of IDUs in England, Wales and Northern Ireland. Overall 36% (1863/5209) self-reported having a symptom with no trend over time (35% 2006, 37% 2007, 34% 2008). Symptoms were less common in the North East of England; increased with years injecting; and were higher in women, those recently homeless, those recently using a needle exchange, and those injecting both opiates and stimulants. Of those injecting during the previous 4 weeks (n=3733) symptoms were associated with: injecting daily; injecting 10 times a day; injecting into hands, groin, or legs; sharing filters; and reusing water to flush syringes. Symptoms of injection site infections are common in IDUs. Better-targeted preventive interventions are needed, and continued surveillance should assist with assessing the impact of new initiatives.

    Original languageEnglish
    Pages (from-to)1510-1518
    Number of pages9
    JournalEpidemiology and Infection
    Volume138
    Issue number10
    DOIs
    Publication statusPublished - Oct 2010

    Keywords

    • Injecting drug-users (IDUs)
    • skin infections
    • surveillance

    Fingerprint

    Dive into the research topics of 'The extent of injection site infection in injecting drug users: Findings from a national surveillance study'. Together they form a unique fingerprint.

    Cite this